Cargando…

Reply to "Does MAFLD really increase the severity of COVID-19?"

Detalles Bibliográficos
Autores principales:	Pan, Lu, Huang, Pan, Xie, Xia, Xu, Jiachen, Guo, Dawei, Jiang, Yuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641532/ https://www.ncbi.nlm.nih.gov/pubmed/33187919 http://dx.doi.org/10.1016/j.dld.2020.10.034

Ejemplares similares

Does MAFLD really increase the severity of COVID-19?
por: Fajar, Jonny Karunia, et al.
Publicado: (2021)

Metabolic associated fatty liver disease increases the severity of COVID-19: A meta-analysis
por: Pan, Lu, et al.
Publicado: (2021)

Does hair dye use really increase the risk of prostate cancer?
por: Jiann, Bang-Ping
Publicado: (2017)

Does particle disease really exist?
por: Mjöberg, Bengt
Publicado: (2018)

Reply to Sharma and Zeki: Does Vaping Increase Susceptibility to COVID-19?
por: Zhang, Haijun, et al.
Publicado: (2020)

Reply to: ‘Younger patients with MAFLD are at increased risk of severe COVID-19 illness: A multicenter preliminary analysis’
por: Ji, Dong, et al.
Publicado: (2020)

Obesity in total hip arthroplasty—does it really matter?
por: Lübbeke, Anne
Publicado: (2012)

What does 95% COVID-19 vaccine efficacy really mean?
por: Olliaro, Piero
Publicado: (2021)

Reply to Dong et al.: Airway Pressure Release Ventilation: Is It Really Different in Adults and Children?
por: Lalgudi Ganesan, Saptharishi, et al.
Publicado: (2019)

Sodium-glucose co-transporter-2 inhibitors in the intensive care unit setting: do we really need sodium increase, especially in sepsis? Reply
por: Mårtensson, Johan, et al.
Publicado: (2023)

Ethnic disparities in COVID-19: increased risk of infection or severe disease? – Authors' reply
por: Mathur, Rohini, et al.
Publicado: (2021)

Reply to: Hypertension and severe COVID-19
por: Shibata, Shigeru, et al.
Publicado: (2023)

Reply to Letter to Editor: “HER2 positivity in patients with estrogen receptor (ER) positive breast cancer: Is it really prognostic?”
por: Li, Shuai, et al.
Publicado: (2020)

Mavrilimumab for severe COVID-19 – Authors' reply
por: De Luca, Giacomo, et al.
Publicado: (2020)

Is COVID in Neonates Really Mild?
por: Khamkar, Anilkumar M., et al.
Publicado: (2021)

Reply by Pan et al. to Haouzi et al.
por: Pan, Chun, et al.
Publicado: (2020)

Tocilizumab for severe COVID-19 pneumonia – Authors' reply
por: Guaraldi, Giovanni, et al.
Publicado: (2020)

Anakinra for severe forms of COVID-19 – Authors' reply
por: Hayem, Gilles, et al.
Publicado: (2020)

Younger patients with MAFLD are at increased risk of severe COVID-19 illness: A multicenter preliminary analysis
por: Zhou, Yu-Jie, et al.
Publicado: (2020)

Particle disease really does exist: An evidence based rebuttal to Dr. Mjöberg’s opinion letter
Publicado: (2018)

Reply
por: Liu, Fei, et al.
Publicado: (2021)

Is Fibrosis Really Fibrosis?
por: Vijayakumar, Bavithra, et al.
Publicado: (2021)

Increased Serum Adipsin Correlates with MAFLD and Metabolic Risk Abnormalities
por: Pan, Jie, et al.
Publicado: (2023)

Reply
por: Yang, Xu, et al.
Publicado: (2016)

Does antipsychotic use mediate the effect of psychiatric disorders on COVID-19? – Authors' reply
por: Yang, Huazhen, et al.
Publicado: (2021)

Gastrointestinal services in India during COVID-19: does governance matter? – Authors' reply
por: Ramakrishnan, Arulraj, et al.
Publicado: (2021)

Toward a clinically based classification of disease severity for paediatric COVID-19 – Authors' reply
por: Chen, Dong, et al.
Publicado: (2021)

Host or pathogen-related factors in COVID-19 severity? – Authors' reply
por: Okell, Lucy C, et al.
Publicado: (2020)

Microvascular disease in diabetes and severe COVID-19 outcomes – Authors' reply
por: Colhoun, Helen M, et al.
Publicado: (2021)

Reply to Suri et al.: COVID-19 Real-Time RT-PCR: Does Positivity on Follow-up RT-PCR Always Imply Infectivity?
por: Chang, De, et al.
Publicado: (2020)

Reply
por: Xu, Zhilu, et al.
Publicado: (2021)

Hydroxychloroquine treatment does not reduce COVID-19 mortality; underdosing to the wrong patients? – Authors' reply
por: Rentsch, Christopher T, et al.
Publicado: (2021)

Author’s Reply—Is it really COVID-19?
por: Chang, David, et al.
Publicado: (2020)

Reply
por: Lu, Yuanqing, et al.
Publicado: (2022)

Provision of holistic care after severe COVID-19 pneumonia – Authors' reply
por: D'Cruz, Rebecca F, et al.
Publicado: (2021)

Severe COVID-19 as a virus-independent immunothrombotic process – Authors' reply
por: McGonagle, Dennis, et al.
Publicado: (2022)

Multiomics single timepoint measurements to predict severe COVID-19 – Authors' reply
por: Garapati, Kishore, et al.
Publicado: (2023)

Does a placebo effect really occur in dogs afflicted by hip osteoarthritis as measured by force platform gait analysis?
por: Moreau, Maxim, et al.
Publicado: (2013)

Reply to: Lung pathophysiology in patients with long COVID-19: one size definitely does not fit all
por: Barisione, Giovanni, et al.
Publicado: (2023)

Reply to Poddighe
por: Stevenson, Louise, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_8ehfd6ted9fegubeq7es3fo7s8